TY - JOUR
T1 - The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein
AU - Siomi, Haruhiko
AU - Siomi, Mikiko C.
AU - Nussbaum, Robert L.
AU - Dreyfuss, Gideon
N1 - Funding Information:
We thank M. Matunis for help with the antibody production, G. Daly for preparation of the manuscript, and the members of our laboratory for helpful discussions and comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and by grants from the National Institutes of Health to R. L. N. and G. D.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 1993/7/30
Y1 - 1993/7/30
N2 - Fragile X syndrome is one of the most common human genetic diseases and the most common cause of hereditary mental retardation. The gene that causes fragile X syndrome, FMR1, was recently identified and sequenced and found to encode a putative protein of unknown function. Here we report that FMR1 contains two types of sequence motifs recently found in RNA-binding proteins: an RGG box and two heterogeneous nuclear RNP K homology domains. We also demonstrate that FMR1 binds RNA in vitro. Using antibodies to FMR1, we detect its expression in divergent organisms and in cells of unaffected humans, but fragile X-affected patients express little or no FMR1. These findings demonstrate that FMR1 expression is directly correlated with the fragile X syndrome and suggest that anti-FMR1 antibodies will be important for diagnosis of fragile X syndrome. Furthermore, the RNA binding activity of FMR1 opens the way to understanding the function of FMR1.
AB - Fragile X syndrome is one of the most common human genetic diseases and the most common cause of hereditary mental retardation. The gene that causes fragile X syndrome, FMR1, was recently identified and sequenced and found to encode a putative protein of unknown function. Here we report that FMR1 contains two types of sequence motifs recently found in RNA-binding proteins: an RGG box and two heterogeneous nuclear RNP K homology domains. We also demonstrate that FMR1 binds RNA in vitro. Using antibodies to FMR1, we detect its expression in divergent organisms and in cells of unaffected humans, but fragile X-affected patients express little or no FMR1. These findings demonstrate that FMR1 expression is directly correlated with the fragile X syndrome and suggest that anti-FMR1 antibodies will be important for diagnosis of fragile X syndrome. Furthermore, the RNA binding activity of FMR1 opens the way to understanding the function of FMR1.
UR - http://www.scopus.com/inward/record.url?scp=0027327486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027327486&partnerID=8YFLogxK
U2 - 10.1016/0092-8674(93)90420-U
DO - 10.1016/0092-8674(93)90420-U
M3 - Article
C2 - 7688265
AN - SCOPUS:0027327486
SN - 0092-8674
VL - 74
SP - 291
EP - 298
JO - Cell
JF - Cell
IS - 2
ER -